Article Text

Download PDFPDF
Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis
  1. A Primaveraa,
  2. D Audeninoa,
  3. N Maviliob,
  4. L Cocitoa
  1. aDepartment of Neurological and Visual Sciences, University of Genova, Italy, bDepartment of Neuroradiology, Hospital San Martino, Genova, Italy
  1. Dr L Cocito, Department of Neurological and Visual Sciences, University of Genova, Via A De Toni, 5 I-16132 Genova, Italylcocito{at}neurologia.unige.it

Abstract

OBJECTIVES Reversible posterior leucoencephalopathy syndrome (RPLS) may develop in patients with renal insufficiency, hypertension, and immunosuppression, and is managed by prompt antihypertensive and anticonvulsant treatment. Four patients with renal insufficiency and fluid overload associated with Wegener's granulomatosis (one patient) and systemic lupus erythematosus (SLE) (three patients) are described, whose clinical picture and neuroimaging indicated RPLS.

CASE REPORTS All patients had headache, seizures, visual abnormalities, and transient motor deficit, and were hypertensive at the onset of the symptoms. Head computed tomography (CT) scan and magnetic resonance imaging showed predominantly posterior signal abnormalities, which were more conspicuous on T2 weighted spin echo images than on CT scan. All patients had some form of cytotoxic treatment shortly before the syndrome developed, and dramatically responded to blood pressure control and anticonvulsant treatment. In two patients with SLE, dialysis was required for renal insufficiency.

DISCUSSION Follow up neuroimaging studies showed almost complete resolution of signal abnormalities, and suggested that RPLS was associated with cerebral oedema without concomitant infarction. The treatment of hypertension and neurotoxic condition such as uraemia appears of primary importance, while immunosuppressive treatment may cause further damage of the blood-brain barrier.

  • reversible posterior leucoencephalopathy syndrome
  • systemic vasculitis
  • connective tissue disease
  • systemic lupus erythematosus

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.